We found 4 mohs skin cancer surgeons who accept Blue Cross Blue Shield Solution 102, a Multi-State Plan near Houston, TX.

Filter By:
Showing 1-4 of 4
Selecting one of the sort options will cause this page to reload and list providers by the selected sort order.
Dr. Ida Francesca Orengo, MD
Specializes in MOHS-Micrographic Surgery
2002 Holcombe
Houston, TX
 

Dr. Ida Orengo's specialty is MOHS-micrographic surgery. Her areas of expertise include chemical peels, skin biopsy, and skin surgery. Dr. Orengo honors Blue Cross/Blue Shield, Blue Cross Blue Shield Bronze, Blue Cross Blue Shield HMO, and more. After completing medical school at Baylor College of Medicine, she performed her residency at a hospital affiliated with Baylor College of Medicine. Dr. Orengo has received professional recognition including the following: Texas Super Doctors. She is professionally affiliated with Texas Children's Hospital, Houston Methodist, and Michael E. DeBakey VA Medical Center - Main Facility. She welcomes new patients.

Read more

Clinical interests: Chemical Peels, Skin Cancer, Laser Treatment, Mohs Surgery, Skin Biopsy, Scar Removal, Skin ... (Read more)

Mark Price, MD
Specializes in MOHS-Micrographic Surgery
1213 Hermann Drive; Suite 650
Houston, TX
 

Dr. Mark Price's specialty is MOHS-micrographic surgery. Patient reviews placed him at an average of 4.5 stars out of 5. Dr. Price has a special interest in skin cancer. He is affiliated with Memorial Hermann Greater Heights Hospital and Park Plaza Hospital. He takes several insurance carriers, including Blue Cross Blue Shield Bronze, Blue Cross Blue Shield HMO, and Blue Cross Blue Shield Gold. Dr. Price attended Baylor College of Medicine for medical school and subsequently trained at a hospital affiliated with Baylor College of Medicine for residency. He has received the following distinction: Texas Super Doctors. Dr. Price (or staff) speaks Spanish and Vietnamese.

Read more
Featured message: Schedule a Consultation

Clinical interests: Skin Cancer

Ryan W. Ahern, MD
Specializes in MOHS-Micrographic Surgery
1213 Hermann Drive; Suite 650
Houston, TX
 

Dr. Ryan Ahern is a physician who specializes in MOHS-micrographic surgery. The average patient rating for Dr. Ahern is 5.0 stars out of 5. Dr. Ahern has indicated that his clinical interests include skin cancer. He honors several insurance carriers, including Blue Cross Blue Shield Bronze, Blue Cross Blue Shield HMO, and Blue Cross Blue Shield Gold. After attending Tulane University School of Medicine, he completed his residency training at Shands HealthCare and a hospital affiliated with Tulane University. Awards and/or distinctions Dr. Ahern has received include Texas Rising Stars and Texas Super Doctors. Dr. Ahern (or staff) speaks Spanish and Vietnamese. Dr. Ahern's hospital/clinic affiliations include Memorial Hermann Greater Heights Hospital and Park Plaza Hospital.

Read more
Featured message: Schedule a Consultation

Clinical interests: Skin Cancer

Specializes in MOHS-Micrographic Surgery
1401 Binz Street; Suite 200
Houston, TX
 

Dr. Payal Patel's specialty is MOHS-micrographic surgery. She attended medical school at the University of North Texas Health Science Center, Texas College of Osteopathic Medicine. She is in-network for Blue Cross Blue Shield Bronze, Blue Cross Blue Shield HMO, Blue Cross Blue Shield Gold, and more. Dr. Patel has received the following distinction: Texas Rising Stars. Dr. Patel is affiliated with Memorial Hermann.

Read more

Conditions / Treatments

Gender

Insurance

New Patients

Reviews

Medicare Patient Age

Medicare Patient Ethnicity

Medicare Patient Insurance Eligibility

Additional Information

Foreign Language

Online Communication

Patient Demographic

Practice Affiliation

Certifications

Credentials

Fellowship

Medical School

Residency

Years Since Graduation

What is MOHS-Micrographic Surgery?

Mohs micrographic surgery is a surgical treatment for skin cancer that was developed by Dr. Frederick Mohs in the 1930’s. It is the most effective technique for removing the most common types of skin cancer. For the two most common types of skin cancer, basal cell carcinoma and squamous cell carcinoma, Mohs has a 98-99% cure rate. The remarkable thing about Mohs is that it manages to be extremely good at removing all of the cancer cells while at the same time leaving behind most of the healthy tissue, so there is a smaller wound. This makes the procedure safer, speeds up the the recovery time, and minimizes scarring.

During Mohs surgery, skin around the cancer site is mapped out and removed in thin layers. Then each layer is examined under a microscope for cancer cells, while the surgery is in progress. If cancer cells are detected, the surgery continues and another layer is removed. If the skin is clear, the surgery can be stopped. This eliminates the guesswork for surgeons. There is no need to estimate the borders or roots of the cancer and no need to remove a margin of healthy tissue to ensure that all of the cancer is removed.

Even though Mohs has a high cure rate, is safer than other treatments, and takes less tissue, not every skin cancer is treated with Mohs. First, Mohs takes quite a bit longer than traditional surgery because each layer of skin must be carefully cut, prepped, and examined. It is also more expensive and may not always be covered by insurance. In addition, for smaller or less aggressive cancers that are easier to treat, the cure rate for non-Mohs treatments is close to that of Mohs; thus, the extra time and cost of Mohs might not be justified. Other kinds of skin cancer, such as melanoma, are hard to see under a microscope. Since melanoma is so dangerous, Mohs has traditionally not been used to treat it, as there is too much risk for missed cancer cells being left behind in the body. However, recent developments in stains (which make cancer cells more visible under a microscope) may change the role of Mohs in melanoma treatment.

Mohs microsurgery has changed the way doctors treat skin cancer in the past 80 years, and it continues to gain in popularity as it increases the effectiveness and safety of skin cancer treatment.
Selecting a checkbox option will refresh the page.